Title
Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds
Date Issued
13 May 2015
Access level
metadata only access
Resource Type
journal article
Author(s)
Ribeiro T.G.
Nascimento A.M.
Henriques B.O.
Franca J.R.
Duarte M.C.
Lage P.S.
Andrade P.H.R.
Lage D.P.
Rodrigues L.B.
Costa L.E.
Martins V.T.
Faraco A.A.G.
Coelho E.A.F.
Castilho R.O.
Publisher(s)
Elsevier Ireland Ltd
Abstract
Ethnopharmacological relevance Stryphnodendron obovatum Benth. is a Brazilian tree used to treat skin ulceration, promote wound healing, and inhibit the growth of protozoa, including Trypanosoma and Leishmania species. Bioguided fractionation of the ethanol extract of S. obovatum stem bark was performed, and antileishmanial and antioxidant activities of the standardized fractions were analyzed. Materials and methods Stationary-phase Leishmania amazonensis promastigotes, murine macrophages, and human red blood cells (RBCs) were exposed to plant extract, standardized fractions or isolated compounds for 48 h at 37 °C to evaluate their antiparasitic activity and cytotoxicity. The 2,2-diphenyl-1-picryl-hidrazyl assay was used to evaluate antioxidant activity. Results The S. obovatum extract and fractions showed antileishmanial and antioxidant activity; however, the organic fraction (OF) showed the best efficacy. We identified gallic acid, gallocatechin, epigallocatechin, catechin, and epigallocatechin gallate in the OF fraction. These compounds effectively inhibited L. amazonensis activity, with gallic acid, gallocatechin, and epigallocatechin gallate showing the highest selectivity. Furthermore, the evaluated compounds had no significant effect on murine macrophages and human RBCs. Conclusions The compounds present in the S. obovatum plant bark ethanol extract may provide an alternative therapeutic approach for L. amazonensis treatment.
Start page
238
End page
242
Volume
165
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Scopus EID
2-s2.0-84925436629
PubMed ID
Source
Journal of Ethnopharmacology
ISSN of the container
03788741
Sponsor(s)
This work was supported by Grants from Pró-Reitoria de Pesquisa from UFMG (Edital 01/2014). The authors thank the Instituto Nacional de Ciência e Tecnologia em Nano-biofarmacêutica (INCT-Nanobiofar), FAPEMIG ( CBB-APQ-02364-08 and CBB-APQ-00496-11 ), FUNDECT ( 41/100172/05 ), and CNPq ( APQ-471374/2004-0APQ-472090/2011-9 and APQ-482976/2012-8) .
Sources of information: Directorio de Producción Científica Scopus